Alesco Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Alesco Advisors's VRTX Position: Q2 2026 in Review
Alesco Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 75% in Q2 2026, selling an estimated $608K and leaving 454 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #206.
Alesco Advisors first reported a position in VRTX in Q4 2019 and has held it in 3 quarters since. The position peaked at $815K in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Alesco Advisors held 454 shares of Vertex Pharmaceuticals worth $226K as of Q2 2026.
- Alesco Advisors sold 1,371 Vertex Pharmaceuticals shares in Q2 2026, an estimated $608K.
- Vertex Pharmaceuticals made up 0.01% of Alesco Advisors's portfolio in Q2 2026, its #206 holding.
- Alesco Advisors first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 3 quarters since.
- Alesco Advisors's Vertex Pharmaceuticals position peaked at $815K in Q1 2026.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Alesco Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.